Katie E. Hebron

Also affiliated with Frederick National Laboratory for Cancer Research, Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models”.

The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1646

N/A

0DataRank · unranked

21 citations

Xiaolin Wan, Jacob S. Roth, David J. Liewehr, Nancy E. Sealover, William J.E. Frye +29 more

Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma

Cancers(2024)10.3390/cancers16132320

N/A

0DataRank · unranked

6 citations

Jacob S. Roth, Edjay R. Hernandez, Joshua T. Kowalczyk, Nancy E. Sealover, Katie E. Hebron +17 more

ASAP1 and ARF1 Regulate Myogenic Differentiation in Rhabdomyosarcoma by Modulating TAZ Activity

Molecular Cancer Research(2024)10.1158/1541-7786.mcr-24-0490

N/A

0DataRank · unranked

3 citations

Olivia L. Perkins, Angela Kim, Xiaoying Jian, Sofia A. Girald-Berlingeri, Haiyan Lei +5 more